# DOVATO
> **NDA211994** · New Drug Application · Sponsor: VIIV HLTHCARE · Approved 2019-04-08
## Drug
- **FDA Application Number:** NDA211994
- **Application type:** New Drug Application
- **Brand name:** DOVATO
- **Generic name:** DOLUTEGRAVIR SODIUM AND LAMIVUDINE
- **Active ingredients:** DOLUTEGRAVIR SODIUM; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VIIV HLTHCARE
- **Manufacturer:** ViiV Healthcare Company
- **First approval:** 2019-04-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211994)
---
*AI Analytics · CC0 1.0*